SPY334.89+2.52 0.76%
DIA277.50+3.08 1.12%
IXIC11,167.51+82.26 0.74%

Morgan Stanley Maintains Overweight on Zentalis Pharmaceuticals, Raises Price Target to $49

Morgan Stanley maintains Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Overweight and raises the price target from $45 to $49.

Benzinga · 08/24/2020 12:19
Morgan Stanley maintains Zentalis Pharmaceuticals (NASDAQ: ZNTL) with a Overweight and raises the price target from $45 to $49.